Arkolith/Insider Trading/INBP/Form 4

Riva Sheppard

Co-Chief Executive Officer, Director, 10% OwnerINTEGRATED BIOPHARMA INC (INBP) · full profile →Form 4 · filed Sep 21, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 20, 2023Grant(A)50K$0.09$5K1.3M
May 25, 2023Grant(A)3.4M$0.40$1.4M3.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 20, 2023Disposed to issuer(D)50K—$0200K
May 25, 2023Grant(A)150K—$0150K
May 25, 2023Grant(A)22K—$022K
May 25, 2023Grant(A)67K—$067K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001064900-23-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML